Sage Journals: Discover world-class research

Free access

Research article

First published 2002-05

Evaluation of the Reproductive Toxicity and Embryotoxicity of Insulin Glargine (LANTUS) in Rats and Rabbits

Thomas Hofmann, Georg Horstmann, Ingo Stammberger

International Journal of Toxicology

Free access

Research article

First published 2002-05

Evaluation of the Carcinogenic Potential of Insulin Glargine (LANTUS) in Rats and Mice

Ingo Stammberger, Axel Bube, Beate Durchfeld-Meyer [...]

International Journal of Toxicology

Open access

Research article

First published 2014-8

Clinical effectiveness of Novolin® 30R versus Lantus® combined with Glucobay® treatment in elderly patients with type 2 diabetes mellitus controlled by oral hypoglycaemic agents: A randomized study a

Yixuan Sun, Li Shao, Xianping Niu [...]

Journal of International Medical Research

Retricted access

Research article

First published 2011-01

Titration of Insulin Glargine in Patients with Type 2 Diabetes Mellitus in Asia: Physician- Versus Patient-Led? Rationale of the Asian Treat to Target Lantus Study (ATLAS)

Diabetes Technology & Therapeutics

Retricted access

Research article

First published 2020-9

Real-World Evaluation of Dosing in Patients Converted From Insulin Glargine (Lantus) to Insulin Glargine (Basaglar)

Jamie M. Pitlick, Ginelle A. Bryant, Michael W. Daly [...]

Annals of Pharmacotherapy

Retricted access

Research article

First published 2001-9

Confusion between Lantus and Lente Insulins/Serzone and Seroquel Mixups/Coumadin–Avandia Confusion

Michael R. Cohen

Hospital Pharmacy

Retricted access

Research article

First published 2003-11

Effect of Therapy with Insulin Glargine (Lantus ® ) on Glycemic Control in Toddlers,Children,and Adolescents with Diabetes

Eba H. Hathout, Leigh Fujishige, Jonathan Geach [...]

Diabetes Technology & Therapeutics

Open access

Research article

First published 2019-11

Effectiveness and Safety of Physician-Led Versus Patient-Led Titration of Insulin Glargine in Indian Patients with Type 2 Diabetes Mellitus: A Subanalysis of the Asian Treat to Target Lantus Study (ATLAS)

Anoop Misra, Mayur Patel, Pankaj Agarwal [...]

Diabetes Technology & Therapeutics

Retricted access

Research article

First published 2009-11

Rationale,Design,and Baseline Data of the Insulin Glargine (Lantus) Versus Insulin Detemir (Levemir) Treat-To-Target (L2T3) Study: A Multinational,Randomized Noninferiority Trial of Basal Insulin Initiation in Type 2 Diabetes

Sanne G.H.A. Swinnen, Frank J. Snoek, Marie-Paule Dain [...]

Diabetes Technology & Therapeutics

Retricted access

Research article

First published 2002-6

Insulin Glargine: A New Basal Insulin

Terri L Levien, Danial E Baker, John R White [...]

Annals of Pharmacotherapy

Search results